Navigation Links
Shire Announces Support for Inflammatory Bowel Disease (IBD) Fellowships at Leading Medical Institutions Nationwide
Date:8/31/2010

PHILADELPHIA, Aug. 31 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced its support for inflammatory bowel disease (IBD) fellowships at leading medical institutions across the country.  The six fellowships will begin in 2011 and will provide a year of training in the management of IBD to physicians who recently completed a fellowship in gastroenterology.

"We are proud to support the education of future medical professionals," said Roger Adsett, senior vice president of Shire's gastroenterology business unit.  "As a company committed to advancing gastroenterology, we hope the individuals who complete the Shire-supported fellowships will provide important contributions to bettering patient care."

Institutions receiving support from Shire in the form of charitable contributions include: Cedars-Sinai Medical Center (Los Angeles), Cleveland Clinic, Mayo Clinic (Rochester, Minn.), Mount Sinai Medical Center (New York), University of California, San Francisco, and University of Chicago Medical Center. Shire selected these Centers of Excellence based on the centers' existing fellowship programs.

"Thanks to Shire's generous support, we will be able to increase the number of practicing physicians dedicated to treating inflammatory bowel disease, for which there is a growing need," said Daniel Present, MD, clinical professor of medicine and gastroenterology, at New York's Mount Sinai School of Medicine.  "Fellowships are vital in generating valuable research and improving patient care."

The institutions selected the fellowship recipients in June for fellowships that will begin July 2011.  Medical students were selected for the fellowships by the individual medical institutions based on pre-existing criteria.

For further information
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pentasa(R) - Shire Receives Ruling From FDA on Citizens Petition
2. Shire Purchases Strategic Site in Massachusetts
3. Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals
4. Area Residents Can Give a Little, Help A Lot at Shires BIG GIVE
5. Shire Receives INTUNIV(TM) Paragraph IV Notice Letter From Anchen
6. Excellent Results in a Transformational Year for Shire; Core Product Sales up 25%
7. Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
8. Shire Submits Biologics License Application (BLA) for REPLAGAL(R) With the U.S. Food and Drug Administration (FDA)
9. Shire Expands its Award-Winning ADHD Support Resource, ADHDSupport.com, by Launching an ADHD Twitter(TM) Page
10. Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic
11. Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... BURLINGTON, Mass. , May 21, 2013 ... leading research and advisory firms for pharmaceutical ... of an emerging agent on key efficacy ... disease progression, has the most influence over ... for advanced/metastatic hormone-receptor (HR-) positive, HER2-negative breast ...
(Date:5/21/2013)... CLARA, Calif. , May 21, 2013 ... game-changing embedded-ultrasound platform, today announced the introduction ... that allows complete network-based communications with all ... its latest embedded-ultrasound technology, including this new ... Sao Paulo, Brazil from ...
(Date:5/21/2013)... 21, 2013  The North Shore-LIJ Health System is ... hand-washing compliance at North Shore University Hospital in ... operating rooms at Forest Hills ... The new pilot program strengthens patient safety by ... (ORs), the first time in the US that remote ...
Breaking Medicine Technology:Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4
... June 1, 2011 Mirixa Corporation is pleased to ... licensing agreement for MirixaEdge(SM), a clinical application that supports ... Medication Therapy Management (MTM). Family Physicians Group (FPG), ... Source Pharmacy and selected it as FPG,s preferred pharmacy ...
... YORK, June 1, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0305172/Global-Intravenous-IV-Iron-Drugs-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ... Intravenous (IV) Iron Drugs in US$ Million. ...
Cached Medicine Technology:MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3Global Intravenous (IV) Iron Drugs Industry 2Global Intravenous (IV) Iron Drugs Industry 3Global Intravenous (IV) Iron Drugs Industry 4Global Intravenous (IV) Iron Drugs Industry 5Global Intravenous (IV) Iron Drugs Industry 6Global Intravenous (IV) Iron Drugs Industry 7
(Date:5/21/2013)... May 2013 EMBO announced today that 52 outstanding ... its membership. Forty-three of the researchers reside in Europe ... of nine Associate Members from Canada, China, India, Japan ... around 1600 life scientists. , "Our members are the ... Director Maria Leptin said. "We have been building our ...
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 ... ScripNet and Procura Management, today announced that it ... at Catamaran’s client advisory meeting. Conferred annually, ... partnered with Catamaran to create cutting edge programs ... year, Healthcare Solutions was recognized for its clinical ...
(Date:5/21/2013)... New York, NY (PRWEB) May 21, 2013 ... leukemia, melanoma or non-small cell lung cancer reported that ... behavior in their medicine use, according to new findings ... (NHWS), conducted by Kantar Health . The research ... Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes ...
(Date:5/21/2013)... A plastic surgery Internet marketing ... surgery SEO services following an Internet survey. , ... the “Best Plastic Surgery SEO Services”. , Sources ... predictable. Well-known in the plastic surgery Internet marketing ... any other selection based on superior client results. ...
(Date:5/21/2013)... It’s nearly summer and millions of kids will soon be ... or fall sports. In many cases a physical exam ... , To help parents during this busy time, MedSpring is ... physicals at just $29. As part of the ... perform a physical exam and complete required forms. Patients can ...
Breaking Medicine News(10 mins):Health News:EMBO announces 52 new members for 2013 2Health News:Healthcare Solutions Receives Innovation Award From Catamaran 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2Health News:MedSpring Offers Camp and Sports Physicals For $29 2
... of his other colleagues in the industry with his huge list ... his tour of Europe. ,A source said that ... the tablets are quite difficult to get in Europe. ... are difficult to get in Europe," the Sun quoted the source, ...
... to a new review of studies,doctors are famous for ... of medication errors each year. Electronics to the ... entry systems saw a 66 percent drop in prescription ... are responsible for as much as 61 percent of ...
... Gullotta, said today that the review of childrens television standards by ... a ban on junk food advertising in childrens TV viewing times. ... to the ACMA review and he urged all groups concerned with ... ban on junk food advertising to kids must be a priority ...
... version of a molecule found in the egg cells of ... with the first drug treatment for brain tumours. ... tumour cell and binds to its surface before invading the ... to die. ,In new research published in the ...
... has found that fishes use the threat of punishment ... line and the social order stable. ,Their ... humans, has been hailed by some of the worlds leading ... the Proceedings of the Royal Society of London Series B. ...
... and soft drinks, may seem like harmless snacks and beverages, ... permanent damage to teeth. ,Its known as ... the effect of acid on the teeth that leads to ... of tooth erosion are fundamental to keeping teeth healthy for ...
Cached Medicine News:Health News:Computerized Doctors Order Reduce Prescription Errors 2Health News:Computerized Doctors Order Reduce Prescription Errors 3Health News:Brain Tumor Drug in Frogs A New Report 2Health News:Fishes Use Threat of Punishment in Mating Process 2Health News:Too Much of Acidic Foods can Cause Permanent Damage to Teeth 2
... Quinton Q-Track II Holter Monitoring System uses ... produced the worlds first true 12-lead digital ... presentation of any beat contained in the ... , ,The preprocessing work done by the ...
... an automatic petri dish streaking machine. ... up to 180 pre inoculated petri ... in substantial cost savings. The ISOPLATER® ... standardizes streaking procedures and increases safety ...
Data review and analysis is carried out with the Acquidata Uromac software already supplied with Acquidata Uromac Lab based urodynamics systems...
A compact mobile System Cart gives mobility within your department. The cart accomodates the Uromac Median data processor, desktop computer, printer and provides stowage space. Patient related transd...
Medicine Products: